BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25531193)

  • 1. Effects of bethanechol chloride and distigmine bromide on postvoiding residual volume in patients with underactive bladder.
    Izumi K; Maolake A; Maeda Y; Shigehara K; Namiki M
    Minerva Urol Nefrol; 2014 Dec; 66(4):241-7. PubMed ID: 25531193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the selective acetylcholinesterase inhibitor TAK-802 on the voiding behavior and bladder mass increase in rats with partial bladder outlet obstruction.
    Hashimoto T; Nagabukuro H; Doi T
    J Urol; 2005 Sep; 174(3):1137-41. PubMed ID: 16094081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous activation of muscarinic receptors decreases subsequent non-muscarinic bladder contractions in vivo in the female rat.
    Kullmann FA; Wells GI; McKenna DG; Thor KB
    Life Sci; 2013 Apr; 92(12):733-9. PubMed ID: 23399698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity.
    Harada T; Fushimi K; Kato A; Ito Y; Nishijima S; Sugaya K; Yamada S
    Biol Pharm Bull; 2010; 33(4):653-8. PubMed ID: 20410601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bethanechol chloride for the prevention of bladder dysfunction after radical hysterectomy in gynecologic cancer patients: a randomized controlled trial study.
    Manchana T; Prasartsakulchai C
    Int J Gynecol Cancer; 2011 May; 21(4):730-6. PubMed ID: 21546875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of α1 antagonist and cholinesterase inhibitor on cystometric parameters in lumbar canal stenosis rats with underactive bladder.
    Sekido N; Kida J; Wakamatsu D; Okada H; Matsuya H
    Urology; 2014 Nov; 84(5):1248.e9-15. PubMed ID: 25443946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustainable Effects of Distigmine Bromide on Urinary Bladder Contractile Function.
    Obara K; Tanaka Y
    Pharmacology; 2020; 105(3-4):135-144. PubMed ID: 31614352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of the Long-lasting Potentiating Effect of Distigmine on Urinary Bladder Motility].
    Obara K; Tanaka Y
    Yakugaku Zasshi; 2021; 141(2):245-254. PubMed ID: 33518645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
    Tada M; Fujita N; Umeda M; Koike H; Nagai H
    No To Shinkei; 2004 May; 56(5):415-9. PubMed ID: 15279199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distigmine Bromide Produces Sustained Potentiation of Guinea-Pig Urinary Bladder Motility by Inhibiting Cholinesterase Activity.
    Obara K; Chino D; Tanaka Y
    Biol Pharm Bull; 2017; 40(6):807-814. PubMed ID: 28566624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long-Lasting Enhancing Effect of Distigmine on Acetylcholine-Induced Contraction of Guinea Pig Detrusor Smooth Muscle Correlates with Its Anticholinesterase Activity.
    Obara K; Ogawa T; Chino D; Tanaka Y
    Biol Pharm Bull; 2017; 40(7):1092-1100. PubMed ID: 28674252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case for pharmacotherapy development for underactive bladder.
    Chancellor MB; Kaufman J
    Urology; 2008 Nov; 72(5):966-7. PubMed ID: 18774593
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of distigmine combined with propiverine on bladder activity in rats with spinal cord injury.
    Sugaya K; Nishijima S; Kadekawa K; Ashitomi K; Yamamoto H
    Int J Urol; 2012 May; 19(5):480-3. PubMed ID: 22221137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of distigmine bromide in the treatment of patients with underactive detrusor.
    Bougas DA; Mitsogiannis IC; Mitropoulos DN; Kollaitis GC; Serafetinides EN; Giannopoulos AM
    Int Urol Nephrol; 2004; 36(4):507-12. PubMed ID: 15787326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor.
    Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
    Int J Urol; 2004 Feb; 11(2):88-96. PubMed ID: 14706012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Distigmine on the Mechanical Activity of Urinary Bladder Smooth Muscle.
    Obara K; Tanaka Y
    Biol Pharm Bull; 2019; 42(7):1064-1068. PubMed ID: 31257280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of post-void residual urine volume and bladder voiding efficiency in patients with underactive bladder.
    Yono M; Ito K; Oyama M; Tanaka T; Irie S; Matsukawa Y; Sekido N; Yoshida M; van Till O; Yamaguchi O
    Low Urin Tract Symptoms; 2021 Jan; 13(1):51-55. PubMed ID: 32525267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test.
    Riedl CR; Stephen RL; Daha LK; Knoll M; Plas E; Pflüger H
    J Urol; 2000 Dec; 164(6):2108-11. PubMed ID: 11061937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Lasting Inhibitory Effects of Distigmine on Recombinant Human Acetylcholinesterase Activity.
    Obara K; Chino D; Tanaka Y
    Biol Pharm Bull; 2017; 40(10):1739-1746. PubMed ID: 28966245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underactive Bladder in Older Adults.
    Chuang YC; Plata M; Lamb LE; Chancellor MB
    Clin Geriatr Med; 2015 Nov; 31(4):523-33. PubMed ID: 26476113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.